Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation

Clinical and Experimental Immunology

Volumn 136, Issue 2, 2004, Pages 341-348

  Antonelli, L R V ^a   Dutra, W O ^a   Almeida, R P ^b   Bacellar, O ^b   Gollob, K J ^a,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Av Antonio Carlos 6627 CP   (Brazil)

Author keywords

Cytokines; Immunoregulation; Leishmaniasis; T cells; T helper cells

Indexed keywords

CD45 ANTIGEN; CD69 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; LACK PROTEIN; PARASITE ANTIGEN; PROTOZOAL PROTEIN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ACTIVITY; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEISHMANIA BRAZILIENSIS; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; REGULATORY MECHANISM; SKIN LEISHMANIASIS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, PROTOZOAN; CELLS, CULTURED; CYTOKINES; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; LYMPHOCYTE COUNT; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2142769800     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02426.x     Document Type: Article

References (21)

1. Barral A, Pedral-Sampaio D, Grimaldi JG et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991; 44:536-46.
2. Karplus TM, Jeronimo SM, Chang H et al. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect Immun 2002; 70:6919-25.
3. Mocci S, Coffman RL. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J Immunol 1995; 154:3779-87.
4. Sacks DL, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 2:845-58.
5. Liew FY, Xu D, Chan WL. Immune effector mechanism in parasitic infections. Immunol Lett 1999; 65:101-4.
6. Chatelain R, Varkila K, Coffman RL. IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 1992; 148:1182-7.
7. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med 1994; 179:1367-71.
8. Chatelain R, Mauze S, Coffman RL. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 1999; 21:211-8.
9. Sornasse T, Larenas PV, Davis KA, de Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med 1996; 184:473-83.
10. Bottrel RL, Dutra WO, Martins FA et al. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 2001; 69:3232-9.
11. Pingel S, Launois P, Fowell DJ et al. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope. J Exp Med 1999; 189:1111-20.
12. Coutinho SG, Pirmez C, Da Cruz AM. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients. Trans R Soc Trop Med 2002; 96 (Suppl. 1):S173-S178.
13. Kemp K, Theander TG, Hviid L, Garfar A, Kharazmi A, Kemp M. Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis. Scand J Immunol 1999; 49:655-9.
14. Bacellar O, Lessa H, Schriefer A et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002; 70:6734-40.
15. Follador I, Araujo C, Bacellar O et al. Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infect Dis 2002; 34:E54-E58.
16. Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA. Leishmania major amastigotes initiate the 1-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 1990; 145:4290-7.
17. Boussiotis VA, Tsai EY, Yunis EJ et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105:1317-25.
18. Pompeu MM, Brodskyn C, Teixeira MJ et al. Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect Immun 2001; 69:7453-60.
19. Rogers KA, DeKrey GK, Mbow ML, Gillespie RD, Brodskyn CI, Titus RG. Type 1 and type 2 responses to Leishmania major. FEMS Microbiol Lett 2002; 209:1-7.
20. Rocha-Vieira E, Ferreira E, Vianna P et al. Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-1-cysteine. Immunology 2003; 108:401-8.
21. Bourreau E, Prevot G, Gardon J et al. LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection. Infect Immun 2002; 70:3122-9.